Hello – thank you for reading! At Mayo Clinic we work closely with our Office of Research and Regulatory Support to ensure our providers are in full compliance with current federal regulations when using regenerative products, including cellular, non-cellular and tissue products, for medical conditions. Additionally, experts in the Center for Regenerative Medicine regularly engage the FDA when conducting scientific clinical trials, putting in action the recognized principles of safe and responsible translation of regenerative therapies in line with FDA recommended best practices for scientists and providers in the regenerative medicine space. Additionally, the FDA granted permission for the procedure in this article through IND (Investigational New Drug) use.
Hello – thank you for reading! At Mayo Clinic we work closely with our Office of Research and Regulatory Support to ensure our providers are in full compliance with current federal regulations when using regenerative products, including cellular, non-cellular and tissue products, for medical conditions. Additionally, experts in the Center for Regenerative Medicine regularly engage the FDA when conducting scientific clinical trials, putting in action the recognized principles of safe and responsible translation of regenerative therapies in line with FDA recommended best practices for scientists and providers in the regenerative medicine space. Additionally, the FDA granted permission for the procedure in this article through IND (Investigational New Drug) use.